|
COPYRIGHT 2003 International Medical News Group
In "New Rosacea Gel May Outperform Metronidazole" (May 2003, p. 24), those patients who were treated with metronidazole in the randomized, double-blind trial of 251 patients had a 42% decrease in facial erythema, not a 56% decrease.
The headline of the report "Lymphoma Risk No Higher in TNF-Blocker Users...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
